Lemonaid Health tirzepatide review
Advertised at $229, billed at $348. Position 12 of 18 on our board.
Updated 2026-09-18
DISCLOSURE — Coreage Rx pays this desk a commission when a reader signs up through our link. It buys no ranking, no score and no deletions. Method: how we rate. Full terms: disclosure.
Established platform, real multi-month discounts, and a $49 monthly membership behind every tier.
Month-to-month: $299 medication plus $49 membership, about $348. Six months: medication drops to $229, so roughly $278 all in.
The numbers
| Lemonaid Health · tirzepatide | |
|---|---|
| Advertised | $229/mo |
| Membership | $49/mo |
| Billed | $348/mo |
| Advertised-to-billed gap | +$119/mo |
| Per year | $4,176 |
| Board position | 12 of 18, cheapest first |
Month-to-month medication is $299 plus the $49 membership. Committing to six months brings the medication to $229, so about $278 all in.
Where the gap is
Two. The $49 membership charged beside the medication, and an advertised "from $129" that describes neither the monthly nor the six-month injection price.
Against the board
Between about $3,336 and $4,176 a year depending on commitment. Upper half of the board.
| Programme | Advertised | Billed | Gap | Vs board floor |
|---|---|---|---|---|
| Coreage Rx | $149 | $199 | +$50 | +$74/mo |
| Trimi | $125 | $125 | none | — |
| Ozari Health | $125 | $125 | none | — |
| Fifty 410 | $133 | $133 | none | +$8/mo |
| PlexusDx | $129 | $189 | +$60 | +$64/mo |
| Ivím Health | $199 | $199 | none | +$74/mo |
| Zealthy | $216 | $216 | none | +$91/mo |
| Hims & Hers | $199 | $238 | +$39 | +$113/mo |
How the programme works
Long-running telehealth platform offering compounded GLP-1s on monthly and multi-month plans, with a separate monthly membership.
Verified facts
- GLP-1 programmes advertised from $129/month.
- Membership is $49/month after the first month.
- Compounded tirzepatide: $299/month monthly, $249/month on a 3-month plan, $229/month on a 6-month plan.
- A compounded tirzepatide microdose tier is listed at $199/month.
- Medication is billed separately from the membership.
Checked 2026-09-18. This market re-prices without notice — anything older than a month is a starting point, not a quote.
For it
- Multi-month plans cut the medication price substantially.
- An established platform with a long operating history in telehealth.
- Microdose tier available for people who want a gentler option.
Against it
- The $49 monthly membership is charged on top of every medication tier.
- The advertised "from $129" does not describe the injection price.
Read this bit. Add $49/month to every price you are quoted. The advertised $129 is a programme floor, not the injection cost.
Score
3.5 out of 5 on our rubric, which is fixed before assessment and published on how we rate.
| Criterion | Weight | Score |
|---|---|---|
| True monthly cost | 30% | 3.4 / 5 |
| Price honesty | 20% | 3.2 / 5 |
| Clinical support | 20% | 3.8 / 5 |
| Pharmacy sourcing | 15% | 3.6 / 5 |
| Cancelling | 15% | 3.6 / 5 |
Verdict
Longevity has value; $588 a year of membership is what you pay for it here. Only the six-month tier competes.
More from the desk
- Coreage Rx tirzepatide review
Advertised at $149, billed at $199. Position 1 of 18 on our board.
- Trimi tirzepatide review
Advertised at $125 and billed at $125 — no gap. Position 2 of 18 on our board.
- Ozari Health tirzepatide review
Advertised at $125 and billed at $125 — no gap. Position 3 of 18 on our board.
- Cheapest right now
Every programme sorted on what it bills, not what it advertises. Floor: $199/mo tirzepatide, $149/mo semaglutide.
- Six fee traps
Every advertised-to-billed gap on our board comes from one of these six structures. Learn them and you can read any of these sites in ninety seconds.
- Where the traps are
The biggest advertised-to-billed gaps on our board, and the programmes charging most for the same category of medication.